SciSparc Ltd.

scisparc.com

Formerly NasVax, Therapix Biosciences

High-Tech Company
Public Company

(NASDAQ CM: SPRC)

Graduated from: Meytav

TECH VERTICALS

Biotechnology, Cancer, Chronic Pain, Medical Cannabis, MedTech, Neurodegenerative Diseases, Therapeutics

General Data

Sector

Biomed

TECHNOLOGY

SciSparc’s proprietary compounds capitalize on the biochemistry of receptors that specialize in modulating the central nervous system to create therapeutics that mitigate the adverse symptoms associated with CNS disorders.

CONTACT INFO

Personal Contact Information

Blog

Expand / Collapse All

	MANAGEMENT

Key Executive

	BOARD

Board

	FINANCIAL ROUNDS

Round

Date

Stage

Amount

Valuation

PIPE

Oct. 11, 2023

Initial Revenues

$5m

N/A

General Info

Angel Company & Title
E-mail
Website
No. of Current Portfolio Companies
Remarks

Business Description

Description
Angel Activity

Investment Data

Managed Capital
Capital Remarks
Capital Available

Preferences

Maximum investments
Minimum investments
Type of Financing
Stage Preferences
Phase Preferences
Industry Preferences

	SECTOR SEGMENTATION (By Number Of Companies)

Current Israeli Clients (#)

	Deals Underwritten (#)

	Deals Legally Advised (#)

	Current Positions

	Previous Positions

	Background

	Education

	Specialties

Last Updated:	Oct 15, 2023
IVC Number:	A1000000005230